Skip to main content

Table 3 Vital signs after autologous E.coli autovaccine application

From: Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial

 

Heartbeat/min.

Body temperature [°C]

 

0'

30'

60'

90'

120'

0'

30'

60'

90'

120'

Subject No. 1

median

75.0

72.0

74.0

75.0

72.0

36.4

36.2

36.2

36.4

36.4

SD

6.03

6.55

5.31

5.15

5.27

0.68

0.69

0.64

0.62

0.57

Subject No. 2

median

86.0

83.5

83.0

80.0

77.5

36.8

37.0

37.0

36.9

36.8

SD

6.55

12.2

11.2

12.5

9.72

0.32

0.309

0.207

0.2

0.19

Subject No. 3

median

64.0

64.0

62.0

58.0

59.0

36.2

36.3

36.3

36.4

36.2

SD

8.88

5.4

5.60

8.16

5.66

0.34

0.30

0.31

0.38

0.27

Subject No. 4

median

64

80

78.5

80

78

36.4

36.5

36.7

36.6

36.7

SD

16.0

12.5

13.2

7.8

8.48

0.29

0.37

0.54

0.33

0.29

Subject No. 5

median

76

69.5

70.5

69.0

66.0

36.2

36.3

36.2

36.4

36.3

SD

10.2

12.6

11.7

11.8

7.87

0.20

0.30

0.19

0.26

0.16

Subject No. 6

median

79.0

76.0

74.5

74.0

73.5

36.2

36.20

36.2

36.3

36.3

SD

11.0

7.94

5.82

4.63

5.17

0.22

0.26

0.30

0.27

0.31

Subject No. 7

median

75.0

75.0

68.5

74.5

73.0

36.4

36.2

36.2

36.1

36.2

SD

4.90

5.97

7.87

5.72

5.43

0.33

0.29

0.29

0.21

0.37

Subject No. 8

median

80

80

80

79.5

80

36.1

36.1

36.1

36.1

36.1

SD

6.35

6.16

6.65

7.23

5.81

0.05

0.05

0.05

0.04

0.05

Subject No. 9

median

72

68

68

68

68

36.1

36.1

36.1

36.1

36.1

SD

9.70

10.1

9.51

8.35

8.51

0.05

0.05

0.06

0.04

0.04

  1. SD = standard deviation